Beauty Health’s latest narrative update features a slightly higher price target, with fair value steady at about $1.93 per share while the discount rate nudges up to reflect a bit more perceived risk. Expectations for annual revenue growth remain close to 4.0% as analysts weigh improving execution against ongoing uncertainties around the pace of the turnaround. Read on to see what is driving this cautious optimism and how you can stay ahead of future shifts in the story. Stay updated as the…
Iconic American Fashion
Given that it’s was just 4th of July – a day on which we generally tend to focus on what’s good about the US –










